[Mechanisms by which the bone marrow microenvironment of myelodysplastic neoplasms contributes to disease progression].
作者信息
Hong M H, Chang C K
机构信息
Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Apr 14;44(4):350-352. doi: 10.3760/cma.j.issn.0253-2727.2023.04.018.
Abstract
摘要
相似文献
1
[Mechanisms by which the bone marrow microenvironment of myelodysplastic neoplasms contributes to disease progression].
Zhonghua Xue Ye Xue Za Zhi. 2023 Apr 14;44(4):350-352. doi: 10.3760/cma.j.issn.0253-2727.2023.04.018.
2
[Bone Marrow Microenvironment and Myelodysplastic Syndromes--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):290-4. doi: 10.7534/j.issn.1009-2137.2016.01.056.
3
The immunobiology of myelodysplastic neoplasms: a mini-review.
Front Immunol. 2024 Sep 16;15:1419807. doi: 10.3389/fimmu.2024.1419807. eCollection 2024.
4
Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.
Cytometry A. 2018 Jul;93(9):916-928. doi: 10.1002/cyto.a.23506. Epub 2018 Sep 13.
5
Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Mol Genet Metab. 2015 Sep-Oct;116(1-2):24-8. doi: 10.1016/j.ymgme.2015.07.004. Epub 2015 Jul 20.
6
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
J Vis Exp. 2023 Nov 10(201). doi: 10.3791/66093.
7
Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.
Int J Hematol. 2012 Jan;95(1):17-25. doi: 10.1007/s12185-011-1001-x. Epub 2012 Jan 6.
8
The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
J Stem Cells. 2010;5(2):49-64.
9
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
Mod Pathol. 2014 May;27(5):681-9. doi: 10.1038/modpathol.2013.187. Epub 2013 Nov 1.
10
Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomide.
Haematologica. 2019 Jul;104(7):1355-1364. doi: 10.3324/haematol.2018.208223. Epub 2019 Jan 17.
本文引用的文献
1
[The Latest Research Progress on Myelodysplastic Syndrome Patient-derived Mesenchymal Stem Cell--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Aug;30(4):1286-1290. doi: 10.19746/j.cnki.issn.1009-2137.2022.04.051.
2
IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.
Blood. 2022 Oct 6;140(14):1607-1620. doi: 10.1182/blood.2022016084.
3
The Coming of Age of Preclinical Models of MDS.
Front Oncol. 2022 Mar 16;12:815037. doi: 10.3389/fonc.2022.815037. eCollection 2022.
4
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
Cancer Gene Ther. 2022 Aug;29(8-9):1263-1275. doi: 10.1038/s41417-022-00441-w. Epub 2022 Feb 22.
5
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
Nat Commun. 2021 Oct 25;12(1):6170. doi: 10.1038/s41467-021-26424-3.
6
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.
Blood Adv. 2021 Oct 26;5(20):4112-4124. doi: 10.1182/bloodadvances.2020003055.
7
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20201544. Epub 2021 Jun 15.
8
Oncogenic Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice.
Mol Cancer Res. 2021 Sep;19(9):1596-1608. doi: 10.1158/1541-7786.MCR-20-0275. Epub 2021 Jun 4.
9
Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.
Front Immunol. 2020 Jun 17;11:1236. doi: 10.3389/fimmu.2020.01236. eCollection 2020.
10
Myelodysplastic syndromes: moving towards personalized management.
Haematologica. 2020 Jul;105(7):1765-1779. doi: 10.3324/haematol.2020.248955. Epub 2020 May 21.
Zotero 插件